7 results on '"Betül Sözeri"'
Search Results
2. Catastrophic antiphospholipid syndrome accompanied by complement regulatory gene mutation
- Author
-
Serim Pul, İbrahim Gökçe, Ece Demirci Bodur, Serçin Güven, Neslihan Çiçek, Mehtap Sak, Özde Nisa Türkkan, Deniz Filinte, Cemile Pehlivanoğlu, Betül Sözeri, Harika Alpay, and Pul S., GÖKCE İ., DEMİRCİ BODUR E., Guven S., ÇİÇEK N., SAK M., Turkkan O. N., FİLİNTE D., Pehlivanoglu C., Sozeri B., et al.
- Subjects
complement activation ,Internal Medicine Sciences ,Klinik Tıp ,antiphospholipid antibody syndrome ,human complement factor H-related protein ,Dahili Tıp Bilimleri ,CLINICAL MEDICINE ,Sağlık Bilimleri ,Pediatrics ,Clinical Medicine (MED) ,Tıp ,Çocuk Sağlığı ve Hastalıkları ,Child Health and Diseases ,thrombotic microangiopathy ,THROMBOSIS ,Pediatri ,Health Sciences ,Pediatrics, Perinatology and Child Health ,Medicine ,Klinik Tıp (MED) ,PEDİATRİ ,Pediatri, Perinatoloji ve Çocuk Sağlığı - Abstract
Background. Antiphospholipid syndrome (APS), particularly the catastrophic antiphospholipid syndrome (CAPS), is one of the rare causes of thrombotic microangiopathy (TMA). CAPS is the most severe form of APS, especially when accompanied by complement dysregulation, causes progressive microvascular thrombosis and failure in multiple organs. In this report, a case of CAPS with TMA accompanied by a genetic defect in the complement system is presented.Case. A 13-year-old girl was admitted to the hospital with oliguric acute kidney injury, nephrotic range proteinuria, Coombs positive hemolysis, refractory thrombocytopenia, a low serum complement C3 level and anti-nuclear antibody (ANA) positivity. The kidney biopsy was consistent with TMA. She was first diagnosed with primary APS with clinical and pathological findings and double antibody positivity. As initial treatments, plasmapheresis (PE) was performed and eculizumab was also administered following pulse -steroid and intravenous immunoglobulin treatments. Her renal functions recovered and she was followed up with mycophenolate mofetil, hydroxychloroquine, low dose prednisolone and low molecular weight heparin treatments. The patient presented with severe chest pain, vomiting and acute deterioration of renal functions a few months after the diagnosis of TMA. A CAPS attack was considered due to radiological findings consistent with multiple organ thrombosis and intravenous cyclophosphamide (CYC) was given subsequent to PE. After pulse CYC and PE treatments, her renal functions recovered, she is still being followed for stage-3 chronic kidney disease. Complement factor H-related protein I gene deletion was detected in the genetic study.Conclusions. The clinical course of complement mediated CAPS tends to be worse. Complement system dysregulation should be investigated in all CAPS patients, and eculizumab treatment should be kept in mind if detected.
- Published
- 2023
- Full Text
- View/download PDF
3. Enthesitis: an obscured extraintestinal manifestation in pediatric inflammatory bowel disease
- Author
-
Nelgin Gerenli and Betül Sözeri
- Subjects
medicine.medical_specialty ,Future studies ,Adolescent ,Physical examination ,Disease ,Inflammatory bowel disease ,Crohn Disease ,Internal medicine ,medicine ,Humans ,Child ,Ultrasonography ,medicine.diagnostic_test ,business.industry ,Patellar ligament ,Enthesitis ,Inflammatory Bowel Diseases ,medicine.disease ,Ulcerative colitis ,Cross-Sectional Studies ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Colitis, Ulcerative ,Patella ,medicine.symptom ,business - Abstract
Background Enthesitis is an extra-intestinal manifestation of inflammatory bowel disease (IBD) which often remains underdiagnosed in children. We aimed to evaluate the frequency of enthesitis in pediatric IBD patients using physical examination and ultrasound (US) assessment as the reference standard. Methods 31 children, 7 -18 years of age, diagnosed with IBD were recruited for a cross-sectional study. All subjects completed a study questionnaire and underwent both physical and US examination for the presence of the enthesitis. Results Of 31 subjects (17girls; median age 14(6) years) enrolled, 17 (55%) had ulcerative colitis, 11 (35%) had Crohn`s disease, and 3 (10%) had indeterminate colitis. The median time from IBD diagnosis was 1.2 years. At least one enthesitis (range 1-4) was identified in 14 (45%) patients of whom nine had more than one enthesitis with symmetric involvement in eight. The quadriceps femoris insertion at the superior portion of the patella was the frequently involved site (32%, 9 of 28 sites), followed by patellar ligament insertion at tibial tuberositas. The presence of enthesitis was associated with a higher intensity of the musculoskeletal pain (p=0.018), but physical activity remained unaffected (p=0.056). Conclusions Enthesitis is a common underestimated extra-intestinal manifestation of IBD that may impact the musculoskeletal health of children. Future studies with more extensive cohorts are needed to evaluate enthesial involvement both with physical examination and US in order to predict the long-term outcomes of the enthesitis on children with IBD.
- Published
- 2021
- Full Text
- View/download PDF
4. Elemental mercury intoxication in 7 patients admitted to a pediatric rheumatology clinic
- Author
-
Ayşenur Paç Kısaarslan, Sibel Yel, Zübeyde Gündüz, Hulya Nalcacioglu, Betül Sözeri, Hakan Poyrazoglu, Ruhan Düşünsel, Sümeyra Özdemir Çiçek, Nihal Şahin, and Funda Bastug
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,chemistry.chemical_element ,Renal function ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Rheumatology ,Tubulopathy ,030225 pediatrics ,Internal medicine ,medicine ,Humans ,Acrodynia ,Child ,business.industry ,Elemental mercury ,medicine.disease ,Pediatric rheumatology clinic ,Mercury (element) ,chemistry ,Dimercaptosuccinic acid ,Child, Preschool ,Hypertension ,Mercury Poisoning ,Pediatrics, Perinatology and Child Health ,Severe morbidity ,Female ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Paç Kısaarslan A, Sözeri B, Baştuğ F, Gündüz Z, Yel S, Nalçacıoğlu H, Şahin N, Özdemir Çiçek S, Poyrazoğlu H, Düşünsel R. Elemental mercury intoxication in 7 patients admitted to a pediatric rheumatology clinic. Turk J Pediatr 2019; 61: 786-790. Mercury (Hg) is a toxic heavy metal that can be classified into three groups; organic (methyl), inorganic (mercuric), and elemental (metallic) mercury(Hg0). Mercury intoxication occurs mostly with the elemental form which can potentially damage the function of any organ, or any subcellular structure. The target organ of mercury is the brain, but peripheral nerve function, renal function, immune function, endocrine and muscle function, and several types of dermatitis have been described. We present 7 patients admitted to a pediatric rheumatology clinic with severe extremity pain. One of the patients had acrodynia, two of them had hypertension, two of them had tubulopathy, and three of them had neuropathy. The treatments were Dimercaptosuccinic acid and metalcaptase. In this report, we emphasize that mercury intoxication should be kept in mind with unexplained extremity pain. Timely diagnosis and treatment may prevent severe morbidity and mortality.
- Published
- 2019
- Full Text
- View/download PDF
5. A novel mutation of interleukin-1 receptor antagonist (il1rn) in a dira patient from turkey: diagnosis and treatment
- Author
-
Bengü Gerçeker-Türk, Afig Berdeli, Betül Sözeri, Başak Yıldız-Atıkan, Sevgi Mir, and Ege Üniversitesi
- Subjects
Male ,0301 basic medicine ,030103 biophysics ,medicine.medical_specialty ,Turkey ,Majeed syndrome ,medicine.drug_class ,Disease ,medicine.disease_cause ,Gastroenterology ,0-Belirlenecek ,DIRA ,law.invention ,Frameshift mutation ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,law ,Internal medicine ,medicine ,Humans ,deficiency of interleukin-1 receptor antagonist ,Mutation ,Anakinra ,business.industry ,Hereditary Autoinflammatory Diseases ,Homozygote ,Receptor antagonist ,medicine.disease ,Interleukin 1 Receptor Antagonist Protein ,Interleukin 1 receptor antagonist ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Recombinant DNA ,mutation ,business ,Immunosuppressive Agents ,medicine.drug - Abstract
WOS: 000463332100020, PubMed ID: 30968643, Autoinflammatory diseases can cause severe inflammation in bone and skin such as neonatal-onset multisystem inflammatory disease (NOMID), Majeed syndrome, interleukin-36 receptor antagonist deficiency (DITRA) and deficiency of interleukin-1 (IL-1) receptor antagonist (DIRA) syndrome. Here we report a five-year old boy who was admitted to the hospital with pustular skin lesions and fever in the first month of his life. Molecular analysis of IL1RN gene revealed a single homozygous C nucleotide deletion at nucleotide position 396 (p.Thr133Profs*118). The novel p.Thr133Profs*118 mutation found in our study caused frameshift mutation and as a result, the respective protein is most likely non-functional. The patient, who received a variety of treatments for various preliminary diagnoses until the final diagnosis (DIRA), was treated with recombinant IL-1Ra, anakinra, and experienced significant clinical improvement.
- Published
- 2018
- Full Text
- View/download PDF
6. Arthropathy-like findings and a carpal tunnel syndrome as the presenting features of scheie syndrome: three cases from the same family
- Author
-
Fatih Kardaş, Betül Sözeri, Mustafa Kendirci, and Songul Gokay
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Mucopolysaccharidosis I ,Mucopolysaccharidosis ,Pain ,Disease ,Diagnosis, Differential ,Iduronidase ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Arthropathy ,medicine ,Humans ,Enzyme Replacement Therapy ,Frameshift Mutation ,Carpal tunnel syndrome ,030203 arthritis & rheumatology ,business.industry ,Enzyme replacement therapy ,medicine.disease ,Carpal Tunnel Syndrome ,Pedigree ,Pediatrics, Perinatology and Child Health ,Female ,Joint Diseases ,Differential diagnosis ,business ,Scheie syndrome ,030217 neurology & neurosurgery - Abstract
Gökay S, Kardaş F, Kendirci M, Sözeri B. Arthropathy-like findings and a carpal tunnel syndrome as the presenting features of Scheie syndrome: Three cases from the same family. Turk J Pediatr 2018; 60: 344-347. Mucopolysaccharidosis (MPS) type I is a rare autosomal recessive disease caused by a deficiency of the lysosomal enzyme α-L-iduronidase. MPS I is divided into three subtypes based on the severity of symptoms: Hurler, Hurler-Scheie, and Scheie syndrome (severe, intermediate, and mild forms, respectively). Musculoskeletal involvement may be the only presenting sign in the patients with Scheie syndrome. We have reviewed three cases with prominent features of carpal tunnel syndrome (CTS) at the onset of their disease. Diagnosis was delayed in almost all cases (range 16-19 years). During one year of follow-up period, alleviations of the pain in the hands of patients were observed after enzyme replacement therapy. MPS type I should be considered in the differential diagnosis of the patients with CTS in the first and second decades of life, particularly with stiffness of the fingers and difficulty using the hands without an inflammatory component. An increased awareness of the disease may contribute to more accurate diagnosis, and patients may benefit from early intervention.
- Published
- 2018
- Full Text
- View/download PDF
7. Soft tissue infection caused by Burkholderia cepacia in a child with polyarteritis nodosa
- Author
-
Başak, Yıldız, Muhterem, Duyu, Betül, Sözeri, and Bülent, Karapınar
- Subjects
Soft Tissue Infections ,Humans ,Infant ,Burkholderia Infections ,Female ,Burkholderia cepacia ,Anti-Bacterial Agents ,Polyarteritis Nodosa - Abstract
Burkholderia cepacia belongs to a family of Burkholderia species previously described as Pseudomonas cepacia, especially in patients suffering from cystic fibrosis. There are also many studies about this agent in the last decade due to their life-threatening infections and ability to invade mucosal and cellular surfaces. Here, we report a case of soft tissue infection caused by B. cepacia in a child with an underlying condition of polyarteritis nodosa. Her complaints started at two months of age and she was on cyclosporine therapy. She was treated several times because of soft tissue infections especially in her extremities. The most common causative agents were Pseudomonas spp. and Escherichia coli, but recently, another soft tissue infection accompanied by fever and signs of sepsis had developed. All blood, urine and tissue (debrided from the necrotic area) specimens were incubated. Empirical antibiotherapy with clindamycin was started and cyclosporine therapy was discontinued. B. cepacia was grown in the tissue specimen culture and was only susceptible to carbapenems. Meropenem therapy was administered throughout 14 days with a daily dosage of 60 mg/kg, and she was treated successfully at least in this attack of soft tissue infection, which caused more severe sepsis and tissue damage than the previous infections with other agents.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.